The theme of this proposal is to elucidate the biology of apolipoprotein B (apoB) mRNA editing and provide new insights in the regulation of apoB production. The ultimate goal will be to define the target gene(s) responsible for atherosclerosis and to develop human gene therapy for treatment of hypercholesterolemia. The main focus will involve using adenovirus vector as a gene transfer vehicle to deliver apoB mRNA editing enzyme to study lipoprotein metabolism and to characterize apoB mRNA editing mechanism. ApoB mRNA editing is a unique post-transcriptional modification which results in a single base change in the mRNA, but not the gene. This process is under developmental, species-specific, and tissue-specific metabolic regulation. The essential component, apoB mRNA editing enzyme, that governs that mechanism has been cloned recently. It plays a central role in the regulation of lipoprotein metabolism. Studies will address the role of apoB mRNA editing enzyme in the regulation of apoB production using adenovirus vector as a gene transfer vehicle. A final group of studies will be focused on the characterization of apoB mRNA editing enzyme. of particular interest will be to define the catalytic domain, the role of Leucine-rich motifs, and the modulation of phosphorylation of apoB mRNA editing enzyme. Taken together, these studies should provide a fundamental basis concerning the molecular and biology of apoB mRNA editing and lipoprotein biogenesis. It will also provide us a tool for human gene therapy for the treatment of atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL053441-04
Application #
2609340
Study Section
Metabolism Study Section (MET)
Project Start
1994-12-01
Project End
1998-04-30
Budget Start
1997-12-01
Budget End
1998-04-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Zhong, Shumei; Liu, Chichi; Haviland, David et al. (2006) Simultaneous expression of apolipoprotein B mRNA editing enzyme and scavenger receptor BI mediated by a therapeutic gene expression system. Atherosclerosis 184:264-75
Singh, Uma; Zhong, Shumei; Xiong, Momiao et al. (2004) Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice. Clin Sci (Lond) 106:421-32
Mnjoyan, Zakar H; Dutta, Ranjan; Zhang, Di et al. (2003) Paradoxical upregulation of tumor suppressor protein p53 in serum-stimulated vascular smooth muscle cells: a novel negative-feedback regulatory mechanism. Circulation 108:464-71
Dutta, Ranjan; Singh, Uma; Li, Tong-Bin et al. (2003) Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes. Atherosclerosis 169:51-62
Enjoji, M; Wang, F; Nakamuta, M et al. (2000) Hammerhead ribozyme as a therapeutic agent for hyperlipidemia: production of truncated apolipoprotein B and hypolipidemic effects in a dyslipidemia murine model. Hum Gene Ther 11:2415-30
Teng, B B; Ochsner, S; Zhang, Q et al. (1999) Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization. J Lipid Res 40:623-35
Nakamuta, M; Tsai, A; Chan, L et al. (1999) Sequence elements required for apolipoprotein B mRNA editing enhancement activity from chicken enterocytes. Biochem Biophys Res Commun 254:744-50
Wang, J P; Enjoji, M; Tiebel, M et al. (1999) Hammerhead ribozyme cleavage of apolipoprotein B mRNA generates a truncated protein. J Biol Chem 274:24161-70
Wu, Y; Teng, B B; Brandt, M L et al. (1999) Normal perinatal rise in serum cholesterol is inhibited by hepatic delivery of adenoviral vector expressing apolipoprotein B mRNA editing enzyme (Apobec1) in rabbits. J Surg Res 85:148-57
Teng, B; Ishida, B; Forte, T M et al. (1997) Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1). Arterioscler Thromb Vasc Biol 17:889-97